Far Infrared Radiation Treatment of Dementia and Other Mental Illness

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1

Total Enrollment

4 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-02-29

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This trial is a preliminary study to determine the use of far infrared radiation for the treatment of dementia and other mental sickness.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Far Infrared Radiation Treatment for Osteoarthritis

NCT00573352

Osteoarthritis

UNKNOWN PHASE1

Far Infrared Radiation Treatment for Diabetes

NCT00573456

Diabetes Mellitus

UNKNOWN PHASE1

Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction

NCT00573209

Erectile Dysfunction

UNKNOWN PHASE1

Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism

NCT00573573

Hyperparathyroidism

UNKNOWN PHASE1

The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies

NCT00674843

Muscular Dystrophies

UNKNOWN PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dementia is the progressive decline in cognitive function due to damage or disease in the brain beyond what might be expected from normal aging. Particularly affected areas include memory, attention, language, and problem solving. Especially in the later stages of the condition, affected persons may be disoriented in place and in person (not knowing who they are).

The prevalence of dementia is rising as the global life expectancy is rising. Particularly in Western countries, there is increasing concern about the economic impact that dementia will have in future, older populaces.

It is a disease that is strongly associated with age; 1% of those aged 60-65, 6% of those aged 75-79, and 45% of those aged 95 or older suffer from the disease.

We are postulating that the use of far infrared radiation on the central nervous system, the endocrine system and the viscera will have a positive effect on treating dementia and other neurological illnesses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type OTHER

Far Infrared

Intervention Type RADIATION

Far infrared radiation (5 μm to 20 μm wavelength) for 30 to 40 minutes per treatment session.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Far Infrared

Far infrared radiation (5 μm to 20 μm wavelength) for 30 to 40 minutes per treatment session.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persons age 2 or older, with dementia, Alzheimer's, Huntington's disease, Parkinson's disease, Down's syndrome, multiple sclerosis or stroke

Exclusion Criteria

* Persons with severe mental illness that are confined to mental hospitals etc., as defined by the USA Diagnostic and Statistical Manual of Mental Disorders (DSM)

Minimum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No